The RTK/RAS/MAPK pathway was affected in both mucinous tumors that underwent multi-gene panel testing, in addition to the PI3K/AKT/MTOR pathway or TP53 pathway. This evidence concerns the gene PIK3CA and mucinous neoplasm.